Peer Review History
| Original SubmissionDecember 4, 2019 |
|---|
|
PONE-D-19-33599 Leishmania detection and blood feeding preferences of phlebotomine sand fly species common in the Mediterranean area PLOS ONE Dear Dr. Brianti, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Feb 17 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Vyacheslav Yurchenko Academic Editor PLOS ONE Additional Editor Comments: I invite authors to revise the manuscript to address concerns of both reviewers. Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that you are reporting an analysis of a microarray, next-generation sequencing, or deep sequencing data set. PLOS requires that authors comply with field-specific standards for preparation, recording, and deposition of data in repositories appropriate to their field. Please upload these data to a stable, public repository (such as ArrayExpress, Gene Expression Omnibus (GEO), DNA Data Bank of Japan (DDBJ), NCBI GenBank, NCBI Sequence Read Archive, or EMBL Nucleotide Sequence Database (ENA)). In your revised cover letter, please provide the relevant accession numbers that may be used to access these data. For a full list of recommended repositories, see http://journals.plos.org/plosone/s/data-availability#loc-omics or http://journals.plos.org/plosone/s/data-availability#loc-sequencing 3. In your Methods section, please provide additional location information of the collection sites, including geographic coordinates for the data set if available. 4. In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the collection sites access and, if no permits were required, a brief statement explaining why. 5. Thank you for stating the following in the Financial Disclosure section: 'Sand flies collection in 2018 season has been partially funded by Bayer Animal Health. The founder did not play any role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. Molecular analysis on sand flies were partially founded by the grant Research and Mobility no.015063 awarded by the University of Messina' We note that one or more of the authors have an affiliation to the commercial funders of this research study: Bayer Animal Health GmbH a. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form. Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. b. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. c. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests 6. We note that Figure 1 in your submission contains map/satellite images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (a) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (b) remove the figures from your submission: a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: General comments: Clearly written and comprehensible article bringing interesting information. Title: “…common in the Mediterranean area” – the title is exaggerated – it is definitely not an analysis of sand flies common in the Mediterranean – only in the western part and still not all common species, rather only selected ones, which were common on localities (in Sicily) where the authors made their catches (over only two seasons). PLS change “…common in Sicily”. Introduction should, therefore, also focus primarily on Sicily and, where appropriate, on southern Italy. Most parts describing the faunistic situation should be move from Intro to Discussion. It is really interesting that it was not possible to detect/identify any reptilian blood - it would like to comment on it with at least one sentence. It would be appropriate to include a paragraph where the authors comment on the existence of different haplotypes. There were always two haplotypes for both Leishmania species (L.t. and L.d.), as well as for unnamed trypanosome species - at least they would like to mention or comment this situation. This is particularly interesting in the case of L.donovani / L.infantum - is it really possible to assume that both species were captured/detected? Specific comments: 26. etc. n = XXX 35. etc. (27/82) – not clear, need explanation 36. blood rat 45. why only warm-blooded ? 68. etc. X% or X % 136/137: for more info about the used traps add “see Fig. 1” 160. individually ? = 1866 DNA extractions? 246. You should add the information that obtained sequences (of L.t. and L.d.) were not 100% identical – both species form two “haplotypes” 255. … the same for two left sequences (a monophyletic cluster with another L.t. strain) 259. add information about occurrence in: unfed / blood fed / gravid 264. add Tarentola annularis from Senegal 269. two (2) 270. T. varani / T. sp. Tab 2. n (instead no); n = XY; It would be beneficial to add info about Leishmania/Trypanosoma infection into this table. 316 (express it also in percentage … 96 % - congratulation; and 64 %) 320/Tab 3. rooster ? / hen-chicken-fowl Fig. 4. Unify column color/pattern for presented animals (use the same pattern for the same animal); y axis – better “No. blood fed females” Tabs 3. and 4. Move to Supplementary material ??? 453-4. It is/was not clear that Trypanosoma DNA was detected only in blood fed S.m. females??? This info must be add 327/8 and PLS add also info which blood sources were detected. Reviewer #2: The manuscript describes detection and identification of trypanosomatids and bloodmeals in Sicilian sand flies. Despite the results are interesting, their interpretation is not correct and some parts of the manuscript (mainly Abstract and Introduction) need to be rewritten. General or major comments 1. Some sand fly species studied are NOT „commonly present in the Mediterranean area“ or “common in the Mediterranean area”. Please change the info on lines 22, 125-126, 345-346. Title is also misleading, more specific one would be useful (e.g. “Identification of trypanosomatids and bloodmeals of sand flies in Sicily”). 2. It is necessary to mention (on lines 32-33) that Trypanosoma DNA found in S. minuta clusters with reptile Trypanosomatids. Therefore, finding of Trypanosoma DNA in S. minuta should not be interpreted as a support for S. minuta role in transmission of human pathogens. There is no single evidence that Trypanosoma DNA found originate from species infecting mammals. The sentence on lines 42-43 needs to be changed. 3. Surprisingly, authors did not find a single reptile blood in S. minuta which contradicts frequent finding of reptile trypanosomes. Again, this should be mentioned in the Abstract. 4. Introduction is too long. Text on lines 104-108 and 116-119 could be deleted as most of information is repeated again in Discussion. Table 3 should include also the numbers of females with nonidentified bloodmeals: P. perniciosus (56?) and S. minuta (12?). Table 4 should be moved into Supplement. Minor comments Single finding of Leishmania DNA in P. perniciosus should not be interpreted as confirmation of the vector role of this sand fly species (line 39) or highlighting its role in Mediterranean area (lines 455-456). It may agree with well-known role of this vector with circulation of L. infantum in western Mediterranean. Please, change sentences accordingly. The second sentence of Introduction should be changed. It is not correct in two aspects: 1. There is a single bacterial pathogen transmitted by sand flies (not “plethora” as written by the authors) and number of sand fly-borne viruses is much lower than in mosquitoes. 2. Leishmania of subgenus Mundinia are very likely transmitted by biting midges, not by sand flies. Lines 60-61: Text should be changed to clarify that both information is valid only for western Europe. Line 65: clarify what do you mean by “in free territories” Lines 73-80: Part about imported cases should be reduced or changed. The reference by Fotakis et al (2019) does not concern the Italy. Moreover, this study (published in a good journal) suffers of serious mistakes: only sand fly heads were used for Leishmania DNA and despite of this nonsense extremely high percentage of sand flies were claimed as positive! Such results cannot be trusted and should not be cited. If authors decide to mention/discuss the potential spread L. tropica in Italy, then there are two recent papers about this topic published in Int. J. Parasitol, showing high susceptibility of P. perniciosus and P. tobbi to L. tropica. Lines 363-364: P. sergenti is NOT “the sole vector able to transmit L. tropica”. The vectorial role of P. arabicus is well described in many papers since 2003. Moreover, there are two papers on other sand flies as potential L. tropica vectors published this year, see above. Lines 383-385: the information about potential of L. tarentolae to infect humans is misleading and should be deleted (together with both references). Finding of reptile Trypanosoma in S. minuta is not unexpected (as said on line 404). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Identification of trypanosomatids and blood feeding preferences of phlebotomine sand fly species common in Sicily, Southern Italy PONE-D-19-33599R1 Dear Dr. Brianti, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Vyacheslav Yurchenko Academic Editor PLOS ONE Additional Editor Comments (optional): Authors have adequately addressed all the reviewers' concerns and the manuscript can now be accepted for publication. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I am completely satisfied. The authors have adequately addressed all my comments and I feel that this manuscript is now acceptable for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No |
| Formally Accepted |
|
PONE-D-19-33599R1 Identification of trypanosomatids and blood feeding preferences of phlebotomine sand fly species common in Sicily, Southern Italy Dear Dr. Brianti: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Vyacheslav Yurchenko Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .